Advanced Platforms for Stem Cells Applications
A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Biomaterials".
Deadline for manuscript submissions: closed (10 November 2022) | Viewed by 702
Special Issue Editors
Interests: regenerative medicine; stem cells; microfluidics; oral stem cells; restorative dentistry; osteoregeneration; biomaterials; epithelial–mesenchymal transition; extracellular vesicles; exosomes; liposomes
Special Issues, Collections and Topics in MDPI journals
Interests: regenerative medicine; stem cells; oral stem cells; biomaterials; extracellular vesicles; exosomes; epithelial- mesenchymal transition
Special Issues, Collections and Topics in MDPI journals
Interests: regenerative medicine; stem cells; biomaterials; extracellular vesicles; exosomes; cardiac regeneration; cardiomyocytes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
Mesenchymal stem cells (MSCs) are presently being used in preclinical and clinical trials for their ability to promote tissue regeneration.
Oral tissues have been established to be rich in stem cells from distinctive sources: stem cells from the oral cavity are easily harvestable and have revealed a great plasticity toward the main lineages.
Oral-derived stem cells possess an extraordinary regenerative and therapeutic potential that could be investigated in numerous cell-based regenerative advances.
Oral MSCs are distinguished in the field of tissue engineering/regeneration for their multilineage differentiation potential and simple methods of acquirement.
These cells include periodontal ligament stem/progenitor cells (PDLSCs), dental pulp stem/progenitor cells (DPSCs), stem/progenitor cells from human exfoliated deciduous teeth (SHED), gingival mesenchymal stem/progenitor cells (GMSCs), stem/progenitor cells from the apical papilla (SCAP), and dental follicle stem/progenitor cells (DFSCs).
The current Special Issue considers the use of advanced bioengineered in vitro models, such as microfluidics, organ-on-a-chip (OoCs), scaffolds, bioprinting, and organoids in stem cell research. The integration of MSCs into novel in vitro platforms may contribute enormously to clinical and fundamental research.
Microfluidics devices have been extensively utilized in the medical field and drug discovery process due to their ability to realize an interactive and dynamic cell microenvironment, extremely important to reproduce the cell and organ architectures in vivo. Recent studies have established that microfluidics tool demonstrate the ability to realize an interactive and dynamic cell microenvironment, extremely important to reproduce the cell and organ architectures in vivo. The main application of microfluidics is represented by OoCs technologies.
The integration of MSCs into novel in vitro technologies, such as microfluidics/OoCs, scaffolds, bioprinting, and organoids, can reproduce highly precise and in-vivo-relevant model systems for unlimited research applications, including fundamental studies, drug delivery, and disease models.
We invite authors to contribute with original research articles, reviews, and opinion letters focused on the use of novel technologies, such as microfluidics, organ-on-a-chip (OoCs), scaffolds, bioprinting, and organoids for stem cell applications.
Dr. Guya D. Marconi
Dr. Francesca Diomede
Dr. Jacopo Pizzicanella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Microfluidics
- Oral stem cells
- Stem cells
- Microdevices
- Organ-on-a-chip
- Regenerative medicine
- Drug discovery
- Medical field
- Scaffolds
- Bioprinting
- Organoids
- Spheroids
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
